Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study.

MLA

Zelmat, Yoann, et al. “Incidence of Heart Failure Following Exposure to a Protein Kinase Inhibitor, a French Population-Based Study.” British Journal of Clinical Pharmacology, vol. 89, no. 4, Apr. 2023, pp. 1338–48. EBSCOhost, https://doi.org/10.1111/bcp.15576.

APA

Zelmat, Y., Conte, C., Noize, P., Vabre, C., Pajiep, M., Lafaurie, M., Lapeyre-Mestre, M., & Despas, F. (2023). Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study. British Journal of Clinical Pharmacology, 89(4), 1338–1348. https://doi.org/10.1111/bcp.15576

Chicago

Zelmat, Yoann, Cécile Conte, Pernelle Noize, Clémentine Vabre, Marie Pajiep, Margaux Lafaurie, Maryse Lapeyre-Mestre, and Fabien Despas. 2023. “Incidence of Heart Failure Following Exposure to a Protein Kinase Inhibitor, a French Population-Based Study.” British Journal of Clinical Pharmacology 89 (4): 1338–48. doi:10.1111/bcp.15576.